118 related articles for article (PubMed ID: 25583061)
1. Response to letter regarding article, "plasmin cleavage of von willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy".
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2015 Jan; 131(2):e19-20. PubMed ID: 25583061
[No Abstract] [Full Text] [Related]
2. Letter by Hugenholtz and Lisman regarding article, "plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy".
Hugenholtz GC; Lisman T
Circulation; 2015 Jan; 131(2):e18. PubMed ID: 25583060
[No Abstract] [Full Text] [Related]
3. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
4. Degradation of platelet-von Willebrand factor complexes by plasmin: an alternative/backup mechanism to ADAMTS13.
Chauhan AK
Circulation; 2014 Mar; 129(12):1273-5. PubMed ID: 24449820
[No Abstract] [Full Text] [Related]
5. Binding of von Willebrand factor cleaving protease ADAMTS13 to Lys-plasmin(ogen).
Shin Y; Akiyama M; Kokame K; Soejima K; Miyata T
J Biochem; 2012 Sep; 152(3):251-8. PubMed ID: 22685231
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13.
Chapman K; Seldon M; Richards R
Semin Thromb Hemost; 2012 Feb; 38(1):47-54. PubMed ID: 22314603
[TBL] [Abstract][Full Text] [Related]
7. Methodologies and clinical utility of ADAMTS-13 activity testing.
Just S
Semin Thromb Hemost; 2010 Feb; 36(1):82-90. PubMed ID: 20391299
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of assay methods to measure plasma ADAMTS13 activity in thrombotic microangiopathies.
Palla R; Valsecchi C; Bajetta M; Spreafico M; De Cristofaro R; Peyvandi F
Thromb Haemost; 2011 Feb; 105(2):381-5. PubMed ID: 21103662
[No Abstract] [Full Text] [Related]
9. von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy.
Xu Z; Luo C; Lai P; Ling W; Wu S; Huang X; Huang L; Zhang G; Du X; Weng J
Clin Appl Thromb Hemost; 2020; 26():1076029619892684. PubMed ID: 32088973
[TBL] [Abstract][Full Text] [Related]
10. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic strategy and thrombotic microangiopathy].
Sakai N; Wada T
Nihon Jinzo Gakkai Shi; 2014; 56(7):1082-9. PubMed ID: 25420409
[No Abstract] [Full Text] [Related]
12. Proteolytic inactivation of ADAMTS13 by plasmin in human plasma: risk of thrombotic thrombocytopenic purpura.
Shin Y; Miyake H; Togashi K; Hiratsuka R; Endou-Ohnishi K; Imamura Y
J Biochem; 2018 May; 163(5):381-389. PubMed ID: 29228282
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
14. Plasmin Cleaves Von Willebrand Factor at K1491-R1492 in the A1-A2 Linker Region in a Shear- and Glycan-Dependent Manner In Vitro.
Brophy TM; Ward SE; McGimsey TR; Schneppenheim S; Drakeford C; O'Sullivan JM; Chion A; Budde U; O'Donnell JS
Arterioscler Thromb Vasc Biol; 2017 May; 37(5):845-855. PubMed ID: 28279966
[TBL] [Abstract][Full Text] [Related]
15. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
Zhou Z; Nguyen TC; Guchhait P; Dong JF
Semin Thromb Hemost; 2010 Feb; 36(1):71-81. PubMed ID: 20391298
[TBL] [Abstract][Full Text] [Related]
16. Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation.
Takahashi N; Wada H; Usui M; Kobayashi T; Habe-Ito N; Matsumoto T; Uemoto S; Nobori T; Isaji S
Thromb Res; 2013 Mar; 131(3):225-9. PubMed ID: 23266519
[TBL] [Abstract][Full Text] [Related]
17. The potential therapeutic benefit of targeting ADAMTS13 activity.
Eerenberg ES; Levi M
Semin Thromb Hemost; 2014 Feb; 40(1):28-33. PubMed ID: 24338607
[TBL] [Abstract][Full Text] [Related]
18. von Willebrand factor, shear stress, and ADAMTS13 in hemostasis and thrombosis.
Tsai HM
ASAIO J; 2012; 58(2):163-9. PubMed ID: 22370688
[TBL] [Abstract][Full Text] [Related]
19. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.
Zheng XL
Annu Rev Med; 2015; 66():211-25. PubMed ID: 25587650
[TBL] [Abstract][Full Text] [Related]
20. Keeping von Willebrand Factor under Control: Alternatives for ADAMTS13.
Tersteeg C; Fijnheer R; Pasterkamp G; de Groot PG; Vanhoorelbeke K; de Maat S; Maas C
Semin Thromb Hemost; 2016 Feb; 42(1):9-17. PubMed ID: 26595154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
